Acasti Pharma Inc logo

Acasti Pharma Inc Investor Relations Material

Acasti Pharma Inc., is an Canadian biopharmaceutical company that engages in the development and commercialization of pharmaceutical products for the treatment of dyslipidemia and cardiometabolic risk factors. Its lead drug candidate, CaPre, is a prescription-only medication for the treatment of hypertriglyceridemia. It offers CoregCR, a registered therapeutic formulation of carvedilol for the treatment of hypertension and heart failure for patients with chronic renal impairment

Latest company events

Ticker symbol



Dig deeper into the Acasti Pharma Inc fundamentals on Quartr.

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
App store link
Android play link
Quartr app screenshot